Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients	Disease Attributes, Disease Progression, Nerve Degeneration, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, disease, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder	Not yet recruiting	Not stated	2026-07-30		NCT07737977

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hospital Universitari Vall d'Hebron Research Institute	64
University Hospital, Montpellier	211

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hospital Universitari Vall d'Hebron	Barcelona	Spain	200
Montpellier University Hospital	Montpellier	France	1